000 | 01658 a2200481 4500 | ||
---|---|---|---|
005 | 20250515221711.0 | ||
264 | 0 | _c20110616 | |
008 | 201106s 0 0 eng d | ||
022 | _a1552-4604 | ||
024 | 7 |
_a10.1177/0091270010366446 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWhitfield, Lloyd R | |
245 | 0 | 0 |
_aEffect of gemfibrozil and fenofibrate on the pharmacokinetics of atorvastatin. _h[electronic resource] |
260 |
_bJournal of clinical pharmacology _cMar 2011 |
||
300 |
_a378-88 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAtorvastatin |
650 | 0 | 4 |
_aBiotransformation _xdrug effects |
650 | 0 | 4 | _aCross-Over Studies |
650 | 0 | 4 | _aDrug Interactions |
650 | 0 | 4 |
_aEnzyme Inhibitors _xblood |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFenofibrate _xblood |
650 | 0 | 4 |
_aGemfibrozil _xblood |
650 | 0 | 4 | _aHalf-Life |
650 | 0 | 4 |
_aHeptanoic Acids _xblood |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xblood |
650 | 0 | 4 |
_aHyperlipidemias _xdrug therapy |
650 | 0 | 4 |
_aHypolipidemic Agents _xblood |
650 | 0 | 4 |
_aLactones _xblood |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPyrroles _xblood |
700 | 1 | _aPorcari, Anthony R | |
700 | 1 | _aAlvey, Christine | |
700 | 1 | _aAbel, Robert | |
700 | 1 | _aBullen, William | |
700 | 1 | _aHartman, Daniel | |
773 | 0 |
_tJournal of clinical pharmacology _gvol. 51 _gno. 3 _gp. 378-88 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1177/0091270010366446 _zAvailable from publisher's website |
999 |
_c19770967 _d19770967 |